Humalog ® (insulin lispro)

För fullständig produktresumé för Humalog® se FASS

Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska

Humalog® Insulin: Användning hos patienter med COVID-19 (coronavirus disease 2019)

Användningen av Humalog insulin hos patienter med COVID-19 har inte studerats.

Use of HUMALOG Insulin in Patient With COVID-19

COVID-19 is an infectious respiratory disease caused by SARS-CoV-2, previously referred to as "2019 novel coronavirus."1

Lilly has not studied the use of Humalog insulin in patients with COVID-19 nor in patients at risk of contracting COVID-19.

The Humalog insulin label doesn't state any specific recommendations. However, it does state that insulin requirements may be increased during illness or emotional disturbances.2

Insulin requirements may be increased by substances with hyperglycaemic activity, such as corticosteroids. Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as salicylates (for example, acetylsalicylic acid).2

Clinicians should use their clinical judgment in determining the most appropriate approach in treating a patient with Humalog insulin who has confirmed or suspected COVID-19.

Infectious Disease Resources for COVID-19

For current information on COVID-19, please refer to

References

1. Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization. Accessed March 17, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

2. Humalog [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

3. Coronavirus disease (COVID-19) outbreak. European web page of the World Health Organization. Accessed March 20, 2020. http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19

4. International Diabetes Federation Europe. COVID-19 outbreak: guidance for people with diabetes. https://www.idf.org/our-network/regions-members/europe/europe-news/196-information-on-corona-virus-disease-2019-covid-19-outbreak-and-guidance-for-people-with-diabetes.html. Accessed March 18, 2020

5. COVID-19. European Centre for Disease Prevention and Control. Accessed March 20, 2020. https://www.ecdc.europa.eu/en/novel-coronavirus-china

Glossary

COVID-19 = coronavirus disease 2019

ECDC = European Centre for Disease Prevention and Control

EU WHO = World Health Organization (European regional office)

IDF = International Diabetes Federation

Lilly = Eli Lilly and Company

SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2

Datum fӧr senaste ӧversyn 2020 M03 17

Kontakta Medicinsk Information på Lilly

Kontakta oss på telefon

Kontorstid vardagar 9.00-17.00

Eller så kan du

Skriv din fråga till oss